Solid Biosciences Inc. (SLDB) Dividend History

Company News

• Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

  The dilated cardiomyopathy market is experiencing steady growth, driven by rising prevalence of heart failure, improved diagnostic techniques, and advancements in genetic testing. Increasing R&D investment in gene therapies and novel drug candidates is expanding treatment options.

  GlobeNewswire Inc.

  Featured Companies: AMGN BMY CPIX RCKT
• Rocket Lab stock downgraded by Morgan Stanley due to revised growth outlook By Investing.com - Investing.com

  JPMorgan has upgraded Solid Biosciences' stock from Neutral to Overweight, citing the company's promising gene therapy pipeline and the favorable regulatory environment for its products.

  Investing.com
• This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

  Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. TD Cowen analyst Max Rakhlenko upgraded the rating for Planet Fitness, Inc. (NYSE:PLNT) from Hold to Buy, while raising the price target from $66 to $92. Planet Fitness shares fell 0.4% to close at $72.73 on Friday. See how other analysts view this stock. Roth MKM analyst Eric Handler upgraded Cinemark Holdings, Inc. (NYSE:CNK) from Neutral to Buy and boosted the price target from $19 to $26. Cinemark shares ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: CNK DMRC PLNT SIRI
• FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label

  Following the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation status.

  Zacks Investment Research

  Featured Companies: PFE RGNX SRPT
• Joe Lewis, billionaire owner of Tottenham Hotspur football club, pleads guilty to insider trading

  British billionaire Joe Lewis,  who owns the Tottenham Hotspur football club, has pleaded guilty to insider trading charges in New York, after prosecutors had charged him with sharing secret stock tips with his pilots, girlfriends and assistants for years.

  MarketWatch